ATE66811T1 - Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung. - Google Patents

Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.

Info

Publication number
ATE66811T1
ATE66811T1 AT87401496T AT87401496T ATE66811T1 AT E66811 T1 ATE66811 T1 AT E66811T1 AT 87401496 T AT87401496 T AT 87401496T AT 87401496 T AT87401496 T AT 87401496T AT E66811 T1 ATE66811 T1 AT E66811T1
Authority
AT
Austria
Prior art keywords
sulfamoylbenzamide
aethyl
pyrrolidinyl
methoxy
methyl
Prior art date
Application number
AT87401496T
Other languages
English (en)
Inventor
Pr Peter William Howie
M Alan Mcneilly
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Application granted granted Critical
Publication of ATE66811T1 publication Critical patent/ATE66811T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87401496T 1987-06-30 1987-06-30 Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung. ATE66811T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401496A EP0297191B1 (de) 1987-06-30 1987-06-30 Anwendung von N-[(1-Äthyl-2-pyrrolidinyl)methyl]-methoxy-5-sulfamoylbenzamid zur Sterilitätsbehandlung

Publications (1)

Publication Number Publication Date
ATE66811T1 true ATE66811T1 (de) 1991-09-15

Family

ID=8198226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401496T ATE66811T1 (de) 1987-06-30 1987-06-30 Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.

Country Status (5)

Country Link
EP (1) EP0297191B1 (de)
AT (1) ATE66811T1 (de)
DE (1) DE3772764D1 (de)
ES (1) ES2039255T3 (de)
GR (1) GR3003065T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224895B1 (en) 1996-12-18 2001-05-01 Clemson University Method for promoting ovulation, parturition, and lactation in mammals
US6534526B2 (en) 2001-07-16 2003-03-18 Clemson University Laminitis in horses

Also Published As

Publication number Publication date
ES2039255T3 (es) 1993-09-16
DE3772764D1 (de) 1991-10-10
EP0297191B1 (de) 1991-09-04
GR3003065T3 (en) 1993-02-17
EP0297191A1 (de) 1989-01-04

Similar Documents

Publication Publication Date Title
FI872917A0 (fi) Farmaceutiska baerare, vilka frigoer aktivaemnet reglerbart.
NO168353C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE3853546D1 (de) Vorrichtung zum Positionieren von Gliedmassen von Patienten und torischer chirurgischer Schild.
NO943521D0 (no) Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
ATE66811T1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.
ATE159427T1 (de) Anwendung des n-n-butyl-derivates von desoxynojirimycin zur herstellung eines arzneimittels zur inhibierung von hiv-virus
BG47647A3 (en) Method for preparing of phenothiazinic derivatives
ATE144780T1 (de) Megakaryocytopoietischer faktor
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
DE59010504D1 (de) Typisierung humaner Rhinoviren
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler
NO172339C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv (+)1-((3,4,5-trimetoksy)benzyloksymetyl)-1-fenyl-n,n-dimetyl-n-propylamin
DK661388D0 (da) Fremgangsmaade til fremstilling af thiophenforbindelser
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
ATE144257T1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee